| Oct 3 |
High Growth Tech Stocks To Watch In October 2024
|
| Oct 2 |
Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs
|
| Sep 25 |
Amgen stock falls on lackluster drug data
|
| Sep 25 |
Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
|
| Sep 25 |
argenx: Myositis Data Could Add Billions In Value
|
| Sep 19 |
argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
|
| Sep 13 |
Here’s Why argenx SE (ARGX) Rose 9% in Q2
|
| Sep 6 |
Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
|
| Sep 6 |
Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last?
|
| Sep 4 |
3 Stocks Estimated To Be Up To 45% Below Intrinsic Value
|
